Related Experiment Video

Updated: Jun 23, 2026

Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase (COX/SDH) Double-labeling Histochemistry
06:53

Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase (COX/SDH) Double-labeling Histochemistry

Published on: November 23, 2011

Mitochondrial complementation preventing respiratory dysfunction caused by mutant mtDNA

Akitsugu Sato1, Kazuto Nakada, Jun-Ichi Hayashi

  • 1Graduate School of Life and Environmental Sciences, University of Tsukuba, Ibaraki, Japan.

Biofactors (Oxford, England)
|May 19, 2009
PubMed

Insights

Mitochondrial complementation, due to fusion and fission, prevents respiratory dysfunction from mutant mitochondrial DNA (mtDNA). This finding challenges the mitochondrial theory of aging and supports gene therapy for mitochondrial diseases.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Genetics

Background:

  • The mitochondrial theory of aging posits that accumulated mitochondrial DNA (mtDNA) mutations cause age-related dysfunction.
  • Mitochondria are dynamic organelles undergoing continuous fusion and fission, allowing exchange of mtDNA and products.

Purpose of the Study:

  • To evaluate the mitochondrial theory of aging in light of mitochondrial dynamics.
  • To explore the implications of mitochondrial complementation for disease and therapy.

Main Methods:

  • Review of existing literature on mitochondrial dynamics, mtDNA mutations, and aging.
  • Analysis of the functional consequences of mitochondrial fusion and fission.

Main Results:

  • Mitochondrial fusion and fission facilitate complementation, preventing the expression of respiratory defects caused by pathogenic mtDNA mutations.
  • This complementation mechanism directly contradicts the premise of the mitochondrial theory of aging.

Conclusions:

  • Mitochondrial complementation is a significant factor that counters age-associated mtDNA dysfunction.
  • The existence of mitochondrial complementation supports the potential for gene therapy strategies, such as nuclear transplantation, for mitochondrial diseases.

More Related Videos

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model06:05

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model

Published on: March 9, 2022

Mitochondrial Transformation in Baker's Yeast to Study Translation and Respiratory Complex Assembly09:53

Mitochondrial Transformation in Baker's Yeast to Study Translation and Respiratory Complex Assembly

Published on: June 7, 2024

Related Concept Videos

Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial precursors...